Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RSYRT for Cancer-Related Fatigue
NCT03911921Phase 2Completed
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Jun 2015
- Primary completion
- Feb 2019
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial of Ren Shen Yang Rong Tang in cancer-related fatigue (CRF) (2 arms), sponsored by Peking University Cancer Hospital & Institute. Primary endpoint: Fatigue score at 6 weeks. Started Jun 2015; status: completed.
02
Drugs
Ren Shen Yang Rong Tang
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT03911921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03911921.